ImmuPharma PLC Sustainability Reports

ImmuPharma PLC is a specialty biopharmaceutical company focused on the discovery and development of novel peptide-based therapeutics. Its pipeline primary targets autoimmune diseases, metabolism, and anti-infectives.

Sector: Manufacturing

Country: United Kingdom

Exchange: London Stock Exchange (AIM)

LEI: 213800VZKGHXC7VUS895

FIGI: BBG001SD9RJ9

17 reports from 2006 to 2025

• ImmuPharma PLC 2025 Report and Consolidated Financial Statements
• ImmuPharma PLC 2024 Corporate Governance Report
• ImmuPharma PLC 2024 Report and Consolidated Financial Statements
• ImmuPharma PLC 2023 Report and Consolidated Financial Statements
• ImmuPharma PLC 2022 Report and Consolidated Financial Statements